Skip to main content

Table 1 Clinical characteristics of PCD patients with paediatric-onset and adult-onset perianal disease

From: Perianal disease onset age is associated with distinct disease features and need for intestinal resection in perianal Crohn’s disease: a ten-year hospital-based observational study in China

Factors

Patients with POP (N = 84)

Patients with AOP (N = 209)

P value

Male, n (%)

68 (81.0)

154 (73.7)

0.228

Mean age at CD diagnosis (years ± SD)

18.0 ± 4.3

32.0 ± 10.9

< 0.01

PCD diagnostic delay (months)

12 (2–48)

24 (2.5–60)

0.033

Disease location, n (%)

  

0.198

 L1, terminal ileum

19 (22.6)

55 (26.3)

 

 L2, colon

17 (20.2)

62 (29.7)

 

 L3, ileocolon

45 (53.6)

87 (41.6)

 

 L4, upper gastrointestinal tract

3 (3.6)

5 (2.4)

 

Disease behaviour, n (%)

  

0.015

 B1, non-stricturing, non-penetrating

56 (66.7)

100 (47.8)

0.005a

 B2, structuring

23 (27.4)

88 (42.1)

0.024a

 B3, penetrating

5 (6.0)

21 (10.0)

0.364a

Mean PD onset age (years ± SD)

15.1 ± 2.9

30.2 ± 10.5

< 0.01

Perianal fistula, n (%)

53 (63.1)

110 (52.6)

0.119

 Complex perianal fistula, n/N (%)

38/53 (71.7)

55/110 (50.0)

0.011

Perianal abscess, n (%)

41 (48.8)

100 (47.8)

0.898

Hemorrhoids, n (%)

16 (19.0)

35 (16.7)

0.639

Anal ulcer, n (%)

3 (3.6)

12 (5.7)

0.430

Anal fissures, n (%)

5 (6.0)

8 (3.8)

0.424

Rectovaginal fistula, n (%)

1 (1.2)

9 (4.3)

0.153

Rectal inflammation, n (%)

6 (7.1)

24 (11.5)

0.268

Current smokers, n (%)

4 (4.8)

27 (12.9)

0.040

Family history of IBD, n (%)

4 (4.8))

22 (10.5)

0.117

Medications, n (%)

   

 IFX

28 (33.3)

46 (22.0)

0.044

 Immunomodulators

5 (6.0)

13 (6.2)

0.925

 Antibiotics

51 (60.7)

128 (61.2)

0.933

 Corticosteroids

3 (3.6)

7 (3.3)

1.000

Time from PCD diagnosis to first use of IFX, months (IQR)

1.0 (0.1–1.9)

1.8 (5.3–38.6)

< 0.01

Numbers of IFX uses (mean ± SD)

7.7 ± 0.75

7.1 ± 0.6

0.472

History of PSIs, n (%)

66 (78.6)

150 (71.8)

0.245

Frequency of PSIs, n (%)

  

0.284

 1 time

46 (54.8)

118 (56.5)

 

 2 times

15 (17.9)

22 (10.5)

 

 3 times

5 (6.0)

10 (4.8)

 

Types of perianal surgery, n (%)

   

 Incision and drainage

33 (39.3)

68 (32.5)

0.272

 Seton insertion

42 (50.0)

83 (39.7)

0.107

 Fistulectomy

19 (22.6)

52 (24.9)

0.764

 Proctectomy

0 (0)

2 (1.0)

1.000

 De-functioning

1 (1.2)

2 (1.0)

1.000

 Procedure for prolapsing haemorrhoids

7 (8.3)

14 (6.7)

0.624

CD-related intestinal resection, n (%)

4 (4.8)

44 (21.1)

0.001

Indication for surgery, n (%)

  

0.815

 Inflammation

0 (0)

3 (6.8)

 

 Obstruction

2 (50.0)

19 (43.2)

 

 Perforation

1 (25.0)

18 (40.9)

 

 Obstruction combined with perforation

1 (25.0)

4 (9.1)

 

Extent of resected intestine, n (%)

  

0.232

 Partial ileal resection

2 (50.0)

20 (45.5)

 

 Partial colon resection

1 (25.0)

2 (4.5)

 

 Ileocolonic resection

1 (25.0)

22 (50.0)

 
  1. CD Crohn’s disease, PCD perianal Crohn’s disease, PD perianal disease, POP paediatric-onset perianal disease, AOP adult-onset perianal disease, SD standard deviation, IQR interquartile range, PSIs perianal surgical interventions, IFX infliximab, IBD inflammatory bowel disease
  2. aThis was a subgroup analysis of three disease behaviours between the AOP and POP groups